central bank issued digital currency Featured snippets

Helen Piano's profit distribution plan for the first three quarters: it is planned to distribute 0.32 yuan for 10 shares, and Helen Piano (300329) released the profit distribution plan for the first three quarters of 2024 on the evening of December 13, and it is planned to distribute a cash dividend of 0.32 yuan (including tax) to all shareholders for every 10 shares, with an estimated cash dividend of 8,092,400 yuan.Spring Airlines: In November, the company's passenger transport capacity investment (in terms of available seat kilometers) increased by 10.36% year-on-year and decreased by 9.93% quarter-on-quarter; Passenger turnover (in terms of revenue passenger kilometers) increased by 12.73% year-on-year and decreased by 9.92% quarter-on-quarter; The load factor increased by 1.90% year-on-year and 0.02% quarter-on-quarter.Guangdong: In the next five years, 10 billion yuan will be invested to support the development of the tourism industry. On December 12th, a site meeting was held to promote the implementation of the spirit of the provincial tourism development conference in Guangdong. The meeting proposed to promote the implementation of the "three hundred" plan for cultural tourism investment, that is, to promote 100 major projects under construction and 100 key investment projects, to coordinate provincial financial investment of 10 billion yuan to support the development of tourism industry in the next five years, and to accelerate the implementation of the list of 100 major projects under construction and 100 key investment projects. According to the deployment, Guangdong will focus on promoting the implementation of the "three hundred" plan for cultural tourism investment and establishing "three lists" for key cultural tourism projects (namely, the list of projects under construction, the list of investment projects and the list of projects supported by financial funds). According to statistics, there are 103 major cultural tourism projects under construction in Guangdong province, with a total investment of 282.6 billion yuan, and the accumulated investment has reached 74 billion yuan by the third quarter.

Chinese researchers have developed a new type of implantable cranial nerve probe. The reporter learned from Changchun Institute of Applied Chemistry, Chinese Academy of Sciences that Zhang Qiang, a researcher at the institute, and his collaborators have developed a new type of implantable hydrogel neural probe to realize long-term stable monitoring of cranial nerve signals, precise regulation of neural circuits, and preliminary exploration in the application of diagnosis and treatment of severe brain diseases. Related research results were recently published in the international academic journal Advanced Materials. (Xinhua News Agency)The U.S. House of Representatives passed a bill to expand the judiciary.Sony has registered the trademark of space robot. According to media reports, on December 13th, TGA award ceremony was held, and AstroBot won the annual game award. This game was developed by Team ASOBI and released by Sony Interactive Entertainment. According to Tianyancha's intellectual property information, in May 2020, Sony Interactive Entertainment Co., Ltd. applied for registration of two "cosmic robots" trademarks. At present, the educational and entertainment trademarks have been successfully registered, and the scientific instrument trademarks are displayed as "revocation/invalidation application under review". However, according to the trademark documents, a company's application for invalidation of such trademarks has been rejected. In addition, in November 2019, Sony applied to register two trademarks of "Cosmic Robot Search and Rescue Action", which are internationally classified as educational entertainment and scientific instruments. At present, they have all been rejected and are in an invalid state.

Market News: Lotte Chemical will suspend the Johor plant to reduce losses.Yiling Pharmaceutical Co., Ltd.: The application for clinical trial of Lianhua Yuping Granule was approved, and Yiling Pharmaceutical announced that Beijing Yiling, a wholly-owned subsidiary, received the Notice of Approval for Clinical Trial of Drugs approved and issued by National Medical Products Administration on December 12, 2024, and agreed to carry out clinical trial of Lianhua Yuping Granule for qi deficiency syndrome of common cold.Zhengrong Real Estate and others were forced to execute 230 million yuan. According to the information of legal proceedings, recently, Zhengrong Real Estate Holdings Co., Ltd. and Minhou Zhenghong Real Estate Development Co., Ltd. added a piece of information about the person to be executed, with an execution target of more than 230 million yuan. The enforcement court is Fuzhou Intermediate People's Court of Fujian Province.